IDFC Alternatives Exiting Maharashtra Natural Gas (Asia)

IDFC Alternatives, the alternative asset management vertical at infrastructure financing company IDFC, is exiting its five-year old investment in India-based natural gas distributor Maharashtra Natural Gas (MNGL) to India-based compressed natural gas supplier Indraprastha Gas (IGL). IGL will acquire up to a 50 percent stake in MNGL for INR1.9 billion… Read More

IDG Leads US$100 Million Series B Round for China Online Grocer (Asia)

China-focused venture capital firm IDG Capital Partners has led a US$100 million Series B financing round for China-based online grocer Womai.com, with participation from an existing backer, Asia-focused private equity firm SAIF Partners. With operations in Beijing and Shanghai, Womai specializes in selling imported products directly to Chinese consumers… Read More

PAG to Exit Haitong Securities via US$219 Million Sell Down (Asia)

Asia-focused alternative investment fund manager PAG will raise approximately HKD1.7 billion (approximately US$219 million) through the sale of 130.7 million shares in China-based financial services conglomerate Haitong Securities. PAG acquired 219.7 million shares in Haitong for US$300 million in the company’s April 2012 IPO and sold 89 million shares… Read More

Tiger Global and Naspers Lead US$1 Billion Round for Flipkart (Asia)

Indian e-commerce platform Flipkart has raised US$1 billion in a new funding round co-led by existing investors alternative investment firm Tiger Global and global internet services company Naspers. Singapore’s sovereign wealth fund GIC, Accel Partners, DST Global, ICONIQ Capital, Morgan Stanley Investment Management and Sofina also participated in the… Read More

Apax Partners to Invest in Cholamandalam Investment & Finance Company (Asia)

Private equity investment group Apax Partners will invest INR5 billion (approximately US$83 million) in Cholamandalam Investment & Finance Company (CIFCL), the financial services arm of India-based conglomerate Murugappa Group. Apax will subscribe to 50 million compulsorily convertible preference shares, which hold a face value of INR100 (approximately US$1.67) per… Read More

The Carlyle Group, Signet and OrbiMed Partially Exit Claris Lifesciences (Asia)

Private equity firms The Carlyle Group, Signet Healthcare and OrbiMed have partially exited their investment in India-based pharmaceutical company Claris Lifesciences by participating in the company’s buyback offer. Claris Lifesciences offered a buyback issue worth INR2.3 billion (approximately US$39 million) in March 2014. The buyback was offered at a… Read More



(default archive template)